denefil olha volodymyrivna disorder of lipoprotein metabolism. atherosclerosis
TRANSCRIPT
![Page 1: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/1.jpg)
Denefil Olha Volodymyrivna
Disorder of lipoprotein metabolism. Atherosclerosis
![Page 2: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/2.jpg)
• Plasma lipoproteins are produced and secreted by the liver parenchymal cells and epithelial cells of the small intestine.
![Page 3: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/3.jpg)
General structure of lipoprotein.There is a lipid drop inside (nucleus),
which contains triglycerides (TG) and cholesterol esters (ACh).
Membrane covers the nucleus and consists of protein (apoprotein, or apo-), phospholipids (PhL) and non-ester cholesterol (NACh).
The outer membrane of lipoprotein is hydrophilic and inner core is hydrophobic.
Lipoproteins are soluble in water, it is a transport form of lipids in the blood.
![Page 4: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/4.jpg)
• In plasma of healthy people is
• 4-8 g/l - total lipids
• 0.8-1.5 g/l - VLD
• 3,2-4,5 g/l - LDL• 2,7-4,3 g / l -
HDL• 3,9-6,5 mmol/l -
general chylomicrons
![Page 5: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/5.jpg)
Kinds of the lipoproteins
Indexes Chylomicron VLDL, pre--LP
LDL, -LP HDL, -LP
Diameter, nm 500-1000 25-75 19-24 6-12
Chemical structure (%):
Cholesterol 0,5- 3 15-17 35-48 20-37
% Cholesterol esters
46 57 66-70 78
Phospholipids 3-9 13-20 11-30 24-40
Triglycerides 80-95 50-70 5-10 3-5
Protein 1-2 5-12 14-25 45-55
Apoproteins A, B, C, E B, C B, C, E A, C, D, E
![Page 6: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/6.jpg)
The value of cholesterol
• 1. Necessary for maintaining of cell shape
• 2. Together with PL and proteins provides selective permeability of cells to different substances
• 3. Source of sex and steroid hormones
• 4. Source of bile acids
• 5. Necessary for growth of the organism and cell division
![Page 7: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/7.jpg)
Balance of cholesterol
• One day in the human body• 450 mg of cholesterol oxidized to bile acids• 450 mg of cholesterol excreted with faeces• 100 mg of cholesterol excreted with dermal fat
• 300 mg of cholesterol derived from food• 700 mg of cholesterol is synthesized from acetyl-CoA in
the cells of various organs, the highest in the liver and small intestine
• In adult is about 140 grams of cholesterol (93% is in the cells, 7% is transported in the form of LP mainly LDL in plasma).
![Page 8: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/8.jpg)
Аpо-В-receptorАpо-Е-receptor(receptor connects the LDL, depends on Cholesterol needs of the cell)
Role of LP in Cholesterol transport inside the cell. That is due to receptor-mediated mechanism.
It was discovered by American scientists M.Brown and J.Goldstein in 1973-1975
(Nobel Prize in 1985)
Skin fibroblast
Smooth muscles
cell of artery
Lymphocyte
Macrophage
![Page 9: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/9.jpg)
Receptor-mediated endocytosis
![Page 10: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/10.jpg)
Regulation of cholesterol contents• Except the receptor-mediated cholesterol
admission into the cell to regulate the content exists by removing cholesterol from the cell membrane surface. This is done by HDL.
• In blood this cholesterol undergoes etherification
under influence of lecithin-cholesterol-acetyltransferase, is transported to the liver, where partially oxidized to bile acids.
• Normally, these two processes are balanced.
![Page 11: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/11.jpg)
• 10% of the population have congenital molecular abnormalities in cholesterol metabolism or LP:
• 1) increased synthesis of cholesterol, atherogenic LP in the liver and small intestine
• 2) the prevalence of violations outlet of atherogenic LP in the bloodstream by help of HDL
Violation of regulating processes of cholesterol metabolism
![Page 12: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/12.jpg)
Inherited defects in exchange of LP (cause early atherosclerosis and coronary artery disease)
• 1) Tangier disease - (also known as "Familial alpha-lipoprotein deficiency") or Hypoalphalipoproteinemia is a rare inherited disorder characterized by a severe reduction in the amount of high density lipoprotein (HDL), often referred to as "good cholesterol," in the bloodstream.
• 2) familial hypercholesterolemia - genetically caused by the absence or deficiency of receptors on the surface of parenchymatous and connective tissue-type cells
![Page 13: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/13.jpg)
Receptor-mediated and nonreceptor (unregulated) endocytosis (basis of atherosclerosis
development)
![Page 14: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/14.jpg)
Atherosclerosis is the variable combination of changes in arteries intimae, which consists of focal accumulation of lipids, complicated carbohydrates, blood substances, fibrous tissue and calcium, and associated with changes in media (WHO definition)
![Page 15: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/15.jpg)
First experimental model of atherosclerosis was created on rabbits in 1913. Every day
within 3-4 months A.Anichkov added 10 g of Cholesterol in rabbits ration.
“Atherosclerosis is impossible without cholesterol”.
А.N.Аnichkov
![Page 16: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/16.jpg)
Ways of LDL transport in the arterial wall
• 1. Nonspecific unregulated endocytosis
• 2. Through the intercellular channels of endothelial monolayer (action of adrenaline, noradrenaline, serotonin, angiotensin II, histamine)
• 3. Through the damaged endothelial monolayer (nicotine, autoimmune complexes, high blood pressure, turbulent blood flow, push of pulse wave, the tension shift)
![Page 17: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/17.jpg)
Cholesterol metabolism violation
1. Hypercholesterolemia
2. Dislipoproteinemia
а) LDL concentration
b) Kch = (LDL+VLDL)/HDL (high coefficient correlates to higher probability of atherosclerosis)
Endothelium damage 1. Action of Hemodynamic
factorsа) arterial pressure stroke
volume blood push endotheliocytes
displacement and damage
b) Turbulent moving of blood(arch of aorta, bifurcation of
arteries, branching of arteries, winding section - in these places often formed
plaques)
2. Damage by immune complexes
ЕТHIOLOGY
![Page 18: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/18.jpg)
Peculiarities Are produced- in blood- extra cellular space- in arterial wall
Modified LDL
Properties1. They do not interact with
аpоВ- and аpоЕ-receptors 2. They interact with “scavenger
– receptors ”. Entrance of LDL inside the cell results from the gradient concentration (uncontrolled еndocytosis)
3. Supply cholesterol in cells and stimulate put-off of cholesterol in artery walls
Peroxides modified LDL
LDL+Glucose
LDL+protein
LDL+Ig
LDL+glycosaminoglycan
Their accumulation promotes the forming of foam cells
![Page 19: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/19.jpg)
There are persons who have normal concentration of LDL, but suffer from atherosclerosis!
Reducing of HDL concentration is important
Anti atherosclerosis role of HDL
1. Very easy penetration inside the intimae (due to apоprotein-А) and take out cholesterol
2. Reduce coming up of LDL inside endotheliocytes3. Retention of LDL damage by free radicals
4. Increase prostacyclin synthesis and and decrease thrombocytes aggregation
5. Decrease proliferation of the smooth muscle cells, which is induced by LDL
6. Decrease synthesis of glycosaminoglycans by smooth muscle cells
![Page 20: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/20.jpg)
In the occurrence of atherosclerosis there are 4 defining mechanisms:
• 1. Hereditary factors (lipid metabolism associated with mutation of genes, which encoding receptor of cells to low-density lipoprotein: decreasing the quantity of receptors for LDL on the surface of hepatocytes or they are absent; hereditary hyperlipoproteinemy; deficiency of lipoprotein lipase, enzymes of β-oxidation of fatty acids; defects of NO-synthase genes, polymorphisms of genes encoding of angiotensinogen, angiotensin receptors, angiotensin-converting enzyme, and endothelin receptors to them, growth factor of platelets and fibroblasts).
• 2. Lipid metabolism disorders (increase level of total cholesterol above 5.2 mmol/l; serum cholesterol LDL above 4 mmol/l; decrease serum level of high density lipoprotein cholesterol below 0.9 mmol/l).
• 3. Changes in the vascular wall of arteries.• 4. Violation receptors of cells (E.I. Chazov, 1998).
![Page 21: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/21.jpg)
Theories of atherosclerosis• 1. Hypothesis response
to injury
• 2. Monoclonal hypothesis
• 3. Lysosomal theory
![Page 22: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/22.jpg)
![Page 23: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/23.jpg)
Morphological stages of atherosclerosis1) lipid spots 2) fibrous plaques 3) complications: ulceration, calcification,
thrombosis
![Page 24: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/24.jpg)
1 STAGE –
“FOAM CELLS” PATHOGENESIS
Macrophages have main role:
1. They have “scavenger”-
receptors so Cholesterol
comes in macrophage only
due to concentration
gradient
2. They can accumulate a lot
of Cholesterol inside the cell (process is
controlled by HDL)
3. Modified LDL stimulate
macrophages activity
![Page 25: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/25.jpg)
![Page 26: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/26.jpg)
1 STAGE –
“FOAM CELLS”
Migration of macrophage in intimae
Capture of LDL
Decrease of LDL
concentration in intimae
Many macrophages change into “foam cells”
![Page 27: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/27.jpg)
Role of endotheliocytesThere is no deposit of LDL inside the endotheliocytes!!!!!!!!!а) Due to Аpо-В,Е-receptors entrants of LDL is controlledб) Using of scavenger receptors stimulates retroendocytosis
But!!!1. At hypercholesterolemia absorption of LDL is activated.
That causes endotheliocytes proliferation and accumulation of LDL in intimae.
2. Endothelium injury is common uncontrolled penetration of LDL inside the vessel wall.
3. On endothelium surface is activated lipoprotein lipase, which controls dissociation of VLDL into LDL and HDL
1 STAGE –
“FOAM CELLS”
![Page 28: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/28.jpg)
Role of the smooth muscle cellsDeposit of LDL in intimae causes excretion of
hemotaxis factors by endotheliocytes, macrophages and fibroblasts. These substances conduce smooth muscle cell (SMC) hemotaxis into intimae (contractile cells have ability to change in secretory).
What do they do ???1. They absorb of LDL (they have Аpо-В and Аpо-Е
receptors)2. They proliferate (due to thrombocyte growth factor.
Their DNA synthesis activates and mitosis occurs)3. They synthesize collagen, elastin,
glycosaminoglucans (connective tissue matrix of plaque)
1 STAGE – “FOAM CELLS”
![Page 29: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/29.jpg)
2 stage – LIPID SPOTS
They are formed on different parts of
arterial system (in elastic and elastic-muscle type of vessels):
They have different square in different age:
in aorta – 10 % in 10 years,
30-50% in 25-30 years
in coronary arteries are
appear in 15 years
in cerebral arteries are
appear in 35-45 years
![Page 30: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/30.jpg)
There is proved that this stage can be reversible due to prolonged uncholesterol diet
Formation mechanismFoam cells overload by
cholesterol causes their damage. At this time hydrolytic lisosomal enzymes release, which causes necrosis of surround tissue.
2 stage – LIPID SPOTS
Contents of LIPID SPOTS:
- Foam cells
- Моnocytes/macrophages
- Smooth muscle cells
- Lymphocytes
- Free cholesterol
- Connective tissue
Main characteristic – don’t violate blood flow
![Page 31: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/31.jpg)
3 stage – FIBROUS PLAQUE
Cholesterol and lisosomal enzymes
irritates intimae (because they are the foreign bodies)
Excreation of proliferation factors by macrophages, еndotheliocytes, lymphocytes and thrombocytes
SMC migration in intimae and active proliferation collagen and elastin (capsule that isolates place accumulation of cholesterol and damage of blood vessels by lysosomal enzymes)
![Page 32: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/32.jpg)
characteristic- Contents: ЕChol, NEChol,
leavings of elastin and collagen, foam cells, Chol crystals, necrotic mass
- Vessel narrowing- Stage unalterable
- Partial regression (dilipidation) - diet without Cholesterol (150-160mg/dl) during 1,5-2 years
3 stage – FIBROUS PLAQUE
![Page 33: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/33.jpg)
![Page 34: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/34.jpg)
1. THROMBOSIS (due to endothelium
damage)
2. Ulceration(necrotic
disintegration content plaques leads to thinning of its walls)
3. Calcinations(deposit of insoluble
calcium salts)
4 stage - COMPLICATIONS
![Page 35: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/35.jpg)
4 stage - COMPLICATIONS
![Page 36: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/36.jpg)
![Page 37: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/37.jpg)
![Page 38: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/38.jpg)
![Page 39: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/39.jpg)
Risk factors of atherosclerosis development• 1. Irreversible (endogenous)• Age (men over 40, women over 50 years)• Gender (male, anti-sclerotic effect of estrogen, cholesterol in the case of nonatherosclerotic α-
lipoprotein)• Genetic predisposition (sudden death, myocardial infarction or brain stroke in parents: at
age before 50 in men and before 55 in women)
• 2. Inverse (managed)• Smoking• Hypertension• Obesity
• 3. Potential or partially reverse• Hyperlipidemia - Hypercholesterolemia and / or hypertriglyceridemia• Hyperglycemia and diabetes mellitus• Low levels of high density lipoprotein
• 4. Other possible factors• Low physical activity• Emotional stress and / or personality type• Intoxication, infection
![Page 40: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/40.jpg)
![Page 41: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/41.jpg)
![Page 42: Denefil Olha Volodymyrivna Disorder of lipoprotein metabolism. Atherosclerosis](https://reader033.vdocuments.mx/reader033/viewer/2022061614/5697c01a1a28abf838cceeaa/html5/thumbnails/42.jpg)
Thank you for your attention!